Altmetric

Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review

File Description SizeFormat 
Paper Seckl-Braga 27-11-14.docAccepted version134 kBMicrosoft WordView/Open
Title: Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review
Authors: Braga, A
Maestá, I
Short, D
Savage, P
Harvey, R
Seckl, MJ
Item Type: Journal Article
Issue Date: 7-Oct-2015
Date of Acceptance: 9-Jul-2015
URI: http://hdl.handle.net/10044/1/26729
DOI: http://dx.doi.org/10.1111/1471-0528.13617
ISSN: 1470-0328
Publisher: Wiley
Start Page: 1330
End Page: 1335
Journal / Book Title: BJOG - An International Journal of Obstetrics and Gynaecology
Volume: 123
Issue: 8
Copyright Statement: This is the peer reviewed version of the following article: Braga A, Maestá I, Short D, Savage P, Harvey R, Seckl MJ. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review. BJOG 2015, which has been published in final form at https://dx.doi.org/10.1111/1471-0528.13617. This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Sponsor/Funder: National Institute for Health Research
Imperial College Healthcare NHS Trust- BRC Funding
Funder's Grant Number: RDEMC 79560
RDB01 79560
Keywords: Gestational trophoblastic neoplasia
hormonal contraceptives
human chorionic gonadotropin
hydatidiform mole
oestrogen
progestogen
Obstetrics & Reproductive Medicine
11 Medical And Health Sciences
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx